Literature DB >> 33978055

Recent advances in cell membrane coated metal-organic frameworks (MOFs) for tumor therapy.

Weicong Liu1, Qianwen Yan2, Chen Xia1, Xiaoxiong Wang3, Abhinav Kumar4, Yan Wang1, Yiwei Liu5, Ying Pan5, Jianqiang Liu5.   

Abstract

In improving the tumor-targeting ability of metal-organic frameworks (MOFs) for tumor therapy and avoiding the clearance as well as capture by the immune system, there are still several challenges, which limit the development and bio-applications of MOFs. To overcome these challenges, various targeted modification strategies have been proposed. Amongst all the strategies, a promising cell membrane coating method has been explored and utilized for the syntheses of new cell membrane biomimetic MOFs (CMMs). Through such coating, various source cell membranes (e.g., red blood cell, immune cell, cancer cell, platelet, and fusion cell membranes) can be endowed with excellent properties such as long blood circulation, immune escape, and targeting ability. In the presented perspective, the synthetic method, characterization, and research progress in tumor therapy based on CMMs have been summarized. This is because, like many other technologies, the cell membrane coating technology also has several challenges to overcome. Hence, addressing and overcoming such challenges will promote and extend the bio-applications of MOFs which in the future may become a prospective carrier for cancer nano-medicine. Finally, the prospects and challenges of utilizing CMMs for tumor therapy have been discussed.

Entities:  

Year:  2021        PMID: 33978055     DOI: 10.1039/d1tb00453k

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  4 in total

1.  Silver(I)-Tazobactam Frameworks with Improved Antimicrobial Activity.

Authors:  Daniela R Ferreira; Paula C Alves; Alexander M Kirillov; Patrícia Rijo; Vânia André
Journal:  Front Chem       Date:  2022-01-25       Impact factor: 5.221

2.  A nanosized anionic MOF with rich thiadiazole groups for controlled oral drug delivery.

Authors:  Ke Jiang; Weishu Ni; Xianying Cao; Ling Zhang; Shiwei Lin
Journal:  Mater Today Bio       Date:  2021-12-02

Review 3.  Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy.

Authors:  Xuefen Zhao; Chao Yan
Journal:  Nanoscale Res Lett       Date:  2022-03-22       Impact factor: 5.418

4.  Triple-synergistic MOF-nanozyme for efficient antibacterial treatment.

Authors:  Muxue Wang; Xi Zhou; Yunhong Li; Yuqing Dong; Jiashen Meng; Shuai Zhang; Linbo Xia; Zhaozhi He; Lei Ren; Zhiwei Chen; Xingcai Zhang
Journal:  Bioact Mater       Date:  2022-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.